Mizuho raises USA Compression stock price target on strong demand By Investing.com

Mizuho raised USA Compression Partners' price target to $29 from $28 while keeping a Neutral rating, citing structural gas-demand tailwinds, record pricing, and sustained >95% large-horsepower utilization. The firm lifted 2027-29 adjusted EBITDA estimates and sees $10 million to $20 million of run-rate synergies by year-end 2027, with leverage trending toward 3.8x by year-end 2026. The stock trades at $28.29, is up 28% year-to-date, and offers a 7.42% dividend yield, but Mizuho has not modeled any distribution increase yet.

Analysis

The key second-order effect is that compression is becoming a quasi-toll road on North American gas growth: as upstream volumes rise, the bottleneck shifts from molecules to horsepower, which keeps pricing power unusually sticky even in a softer industrial tape. That makes USAC less of a pure cyclical and more of a capacity-constrained infrastructure compounder, with the real earnings lever now coming from utilization discipline and contract repricing rather than just volume growth.

The overlooked competitive dynamic is that OEM bottlenecks can actually widen the moat for the best-capitalized fleet owners. If JW Power’s manufacturing footprint continues to shield supply availability, USAC can preserve market share while peers that depend more heavily on third-party equipment face longer lead times and potentially inferior economics; this should support relative multiple expansion versus smaller operators that cannot self-fund growth.

The main risk is that this story is late-cycle in duration even if not in price: once leverage falls through the mid-3x area, management will have more flexibility to return capital, but the market may already be discounting that optionality. Any slowdown in gas infrastructure capex, a warm winter, or a normalization in horsepower utilization back toward the low-90s would likely compress the valuation quickly because the equity is implicitly pricing in a long runway of tight supply and clean execution.

Consensus appears to be underestimating how much of the upside is already in the stock. The modest price-target raise despite stronger forward estimates suggests the sell side sees limited near-term re-rating unless distribution growth becomes explicit; that creates a classic ‘good business, fair stock’ setup where the best trade may be relative value rather than outright long. The hidden catalyst is a formal dividend-growth framework, which would likely unlock yield-focused ownership and force a rerating, but absent that, upside probably comes from time and delivery rather than multiple expansion.

Key Decisions for Investors

• Hold USAC tactically long only on pullbacks toward the low-$27s; target $29-$30 over 3-6 months, but trim into strength because the market is already paying for much of the near-term balance-sheet improvement.
• Pair trade: long USAC / short a smaller compression peer with greater OEM dependence or weaker balance sheet, using a 6-12 month horizon to express the moat widening from equipment availability constraints.
• Buy a 6-9 month USAC call spread to capture a potential rerating if management signals distribution growth or if utilization remains above 95%; risk/reward is better than stock given limited upside in consensus targets.
• Avoid chasing the dividend yield as a standalone thesis; if leverage stalls above ~4x or gas activity rolls over, the equity can de-rate fast even with a still-healthy payout.
• Set a catalyst watch for the next earnings call and capital-return commentary; if management pre-announces dividend growth or buyback capacity, reassess for a higher-multiple re-entry.